In early 2018, our founder, Jonathan Reis M.D., was approached by a close friend recently diagnosed with stage 4 colon cancer to help him determine the best treatment to allow him to continue with his productive and fulfilling life, extend life expectancy, and maximize his chances of survival. Dr. Reis investigated the standard of care as well as treatment options in development and found HAI to be the most compelling approach for the treatment of stage 4 colon cancer with primary liver involvement. Dr Reis supported his friend through the initial evaluation, pump implant surgery and on-going treatments. Separately, the father of Intera’s co-founder, David Dove M.D., had benefited from HAI therapy as well.